<DOC>
	<DOC>NCT01349803</DOC>
	<brief_summary>This study is primarily a safety study. The primary and secondary endpoints are based on 24-hour Holter monitor assessments obtained on Day 14 relative to baseline.</brief_summary>
	<brief_title>PT003 MDI Cardiovascular Safety Study</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Key Signed written informed consent 40 80 years of age Clinical history of COPD with airflow limitation that is not fully reversible Females of nonchild bearing potential or females of child bearing potential with negative pregnancy test; and acceptable contraceptive methods Current/former smokers with at least a 10 packyear history of cigarette smoking A measured post bronchodilator FEV1/FVC ratio of &lt; or = 0.70 A measured post bronchodilator FEV1 &gt; or = 750ml or 30% predicted and &lt; or = 80% of predicted normal values Able to change COPD treatment as required by protocol Acceptable baseline (Visit 2) Holter monitor recording Key Women who are pregnant or lactating Primary diagnosis of asthma Alpha1 antitrypsin deficiency as the cause of COPD Active pulmonary diseases Prior lung volume reduction surgery Abnormal chest Xray (or CT scan) not due to the presence of COPD Hospitalized due to poorly controlled COPD within 3 months of Screening Clinically significant medical conditions that preclude participation in the study (e.g. clinically significant abnormal ECG, uncontrolled hypertension, glaucoma, symptomatic prostatic hypertrophy) Cancer that has not been in complete remission for at least 5 years Treatment with investigational study drug or participation in another clinical trial or study within the last 30 days or 5 half lives Clinically significant abnormal findings during the baseline Holter recording Patients with a pacemaker or ICD/CRT/CRT_D devices Other inclusion/exclusion criteria as defined by the protocol</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>COPD</keyword>
</DOC>